MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
OPKO Health Total Current Liabilities 2011-2026 | OPK
Annual Total Current Liabilities OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 193 M | 200 M | 213 M | 330 M | 375 M | 249 M | 288 M | 312 M | 263 M | 252 M | 83.1 M | 91.8 M | 52.4 M | 18.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 375 M | 18.8 M | 209 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B |  USA |
 |
Fulgent Genetics
FLGT
|
85 M | $ 17.7 | 0.17 % | $ 545 M | USA |
 |
Guardant Health
GH
|
303 M | $ 126.35 | 5.42 % | $ 15.8 B | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.8 | - | $ 7.96 M | USA |
 |
Agilent Technologies
A
|
1.71 B | $ 115.59 | 0.46 % | $ 35.1 B | USA |
 |
Illumina
ILMN
|
1.55 B | $ 150.39 | 3.56 % | $ 23.9 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 135.62 | 1.01 % | $ 6.34 B | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 7.49 | -17.78 % | $ 9.96 M | USA |
 |
Castle Biosciences
CSTL
|
68.7 M | $ 20.95 | 6.4 % | $ 607 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
31.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 22.16 | 2.88 % | $ 1.18 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 99.21 | -0.85 % | $ 6.7 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 117.27 | 3.0 % | $ 9.67 B |  Irlanda |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 090.21 | -1.01 % | $ 22.5 B |  Schweiz |
 |
NeoGenomics
NEO
|
88.3 M | $ 9.54 | 2.86 % | $ 1.22 B | USA |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 19.06 | 0.11 % | $ 427 M | USA |
 |
Natera
NTRA
|
310 M | $ 203.71 | 1.39 % | $ 20 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 162.85 | 4.02 % | $ 8.07 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 429.53 | 0.1 % | $ 12.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 3.94 | 2.34 % | $ 365 M | USA |
 |
Personalis
PSNL
|
39.6 M | $ 9.35 | 4.59 % | $ 834 M | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 6.28 | -2.39 % | $ 262 M | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
61.4 M | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 64.46 | -0.63 % | $ 3.86 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.46 | -0.4 % | $ 5.65 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 259.05 | 0.24 % | $ 21.6 B | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 453.38 | 1.14 % | $ 171 B | USA |
 |
Waters Corporation
WAT
|
1.24 B | $ 343.34 | 1.37 % | $ 20.4 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.3 | 1.75 % | $ 2.02 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 194.99 | 1.09 % | $ 21.6 B | USA |